D.E. Shaw & Co
CGEN icon

D.E. Shaw & Co’s Compugen CGEN Stock Holding History

D.E. Shaw & Co’s Portfolio CGEN Stock Details CGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-89,078
Closed -$59K – 4887
2022
Q3 		$59K Buy
+89,078
New +$126K ﹤0.01% 4667
2022
Q2 		– Sell
-49,767
Closed -$160K – 5374
2022
Q1 		$160K Buy
+49,767
New +$168K ﹤0.01% 4925
2021
Q4 		– Sell
-60,754
Closed -$363K – 5431
2021
Q3 		$363K Buy
+60,754
New +$407K ﹤0.01% 4256
2021
Q1 		– Sell
-16,186
Closed -$196K – 4091
2020
Q4 		$196K Sell
16,186
-18,546
-53% -$256K ﹤0.01% 3736
2020
Q3 		$564K Buy
+34,732
New +$569K ﹤0.01% 3166
2020
Q1 		– Sell
-81,437
Closed -$486K – 3951
2019
Q4 		$486K Buy
81,437
+28,604
+54% +$147K ﹤0.01% 3411
2019
Q3 		$224K Buy
52,833
+41,142
+352% +$154K ﹤0.01% 3590
2019
Q2 		$45K Buy
+11,691
New +$41.4K ﹤0.01% 3592
2017
Q4 		– Sell
-12,294
Closed -$47K – 3580
2017
Q3 		$47K Sell
12,294
-1,789
-13% -$6.21K ﹤0.01% 3409
2017
Q2 		$54K Buy
+14,083
New +$58.6K ﹤0.01% 3305
2017
Q1 		– Sell
-11,608
Closed -$59K – 3311
2016
Q4 		$59K Sell
11,608
-19,589
-63% -$117K ﹤0.01% 3373
2016
Q3 		$197K Buy
31,197
+4,671
+18% +$31.6K ﹤0.01% 3204
2016
Q2 		$172K Buy
26,526
+7,125
+37% +$47.6K ﹤0.01% 3207
2016
Q1 		$108K Buy
19,401
+8,761
+82% +$45.8K ﹤0.01% 3277
2015
Q4 		$68K Buy
+10,640
New +$69.8K ﹤0.01% 3701
2015
Q1 		– Sell
-24,956
Closed -$208K – 3662
2014
Q4 		$208K Buy
+24,956
New +$192K ﹤0.01% 3790

Other funds holding CGEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

D.E. Shaw & Co's CGEN Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Compugen (CGEN) in Q4 2022, closing a stake of 89,078 shares — an estimated $59K sold.

D.E. Shaw & Co first reported a position in CGEN in Q4 2014 and held it in 16 quarters. The position peaked at $564K in Q3 2020. 74 funds tracked by Wall St. Rank hold CGEN as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Compugen position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 89,078 Compugen shares in Q4 2022, an estimated $59K.
  • D.E. Shaw & Co first reported a position in Compugen in Q4 2014 and held it in 16 quarters.
  • D.E. Shaw & Co's Compugen position peaked at $564K in Q3 2020.
  • 74 funds tracked by Wall St. Rank held Compugen as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.